Denali Therapeutics
DNLI
#4216
Rank
C$3.70 B
Marketcap
C$23.70
Share price
0.06%
Change (1 day)
-16.08%
Change (1 year)

Market capitalization of Denali Therapeutics (DNLI)

Market cap: C$3.70 Billion

As of January 2026 Denali Therapeutics has a market cap of C$3.70 Billion. This makes Denali Therapeutics the world's 4216th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Denali Therapeutics from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026C$3.70 B2.57%
2025C$3.60 B-15.24%
2024C$4.25 B8.21%
2023C$3.93 B-23.25%
2022C$5.12 B-26.17%
2021C$6.94 B-45.8%
2020C$12.80 B485.22%
2019C$2.18 B-17.85%
2018C$2.66 B54%
2017C$1.72 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Denali Therapeutics was reported to be:

C$3.69 Billion
by Nasdaq info icon info icon
C$3.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novocure
NVCR
C$2.22 B-39.75% Jersey
Novavax
NVAX
C$1.63 B-55.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
C$5.09 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
C$0.52 B-85.75%๐Ÿ‡ฌ๐Ÿ‡ง UK